(MENAFN- Trend News Agency)
The spokesman for EU diplomatic chief Josep Borrell: 'The EU
expects Tehran and Washington to take a 'quick decision' on the
final compromise worked out in Vienna to save the 2015 Iran nuclear
deal', Trend reports citing Euronews .
'Everything that could be negotiated has been incorporated into
the final version of the text and it is now up to the signatory
countries to take political decisions,' Peter Stano told
reporters.
'It's yes or no,' he insisted. 'There is no more room for other
compromises,' he said.
'As coordinator of the negotiations, Josep Borrell expects
decisive political decisions. He has not set any deadline, but we
expect all participants to make this decision very quickly,' he
said.
In the event of an agreement, he added, Borrell will convene a
meeting of the foreign ministers of the signatory countries.
'What can be negotiated has been negotiated, and it's now the
final text,' Borrell wrote on Twitter on Monday evening confirming
the end of the talks held in Vienna since April 2021.
The pact, known by its acronym JCPOA, aims to guarantee the
civilian nature of Iran's nuclear programme, accused of seeking to
acquire nuclear weapons despite its denials.
But following the unilateral withdrawal from the agreement in
2018 by the United States under Donald Trump and the reinstatement
of US sanctions that stifle its economy, Tehran has been gradually
backing away from its obligations.
Iran said it was studying the 25-page text. The compromise
allows the United States to return to the agreement with the
lifting of sanctions on Tehran, provided Iran meets its commitments
and stops exceeding prescribed limits on enrichment and other
nuclear activities, Stano said.
The other signatories are Britain, China, France, Germany and
Russia.
The 2015 agreement offered Iran relief from international
sanctions in exchange for drastically limiting its nuclear
programme, which is under strict UN control, and guarantees that it
is not seeking to acquire an atomic bomb, as it has always
claimed.
MENAFN10082022000187011040ID1104673904
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.